Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN | ||||
| Company | Nervgen Pharma Corp | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 4.35 | ||||
| High | 4.35 | ||||
| Low | 4.16 | ||||
| Latest | 4.24 | ||||
| Change | +0.05 | ||||
| % Change | +1.19% | ||||
| Volume | 343,800 | ||||
| 20-Day Average Volume | 229,505 | ||||
| Previous Close | 4.19 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 4.02 | ||||
| 20-Day Raw Stochastic | 62.93% | ||||
| 20-Day Relative Strength | 52.66 | ||||
| Weighted Alpha | +53.59 | ||||
| Today's Opinion | 40% Buy | ||||
| Previous Opinion | 40% Buy | ||||
| Last Month's Opinion | 24% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.44% since 04/08/26 | ||||
| Low | 4.04 on 04/10/26 | ||||
| High | 4.35 on 04/15/26 | ||||
| 1-Month | |||||
| %Chg | +17.78% since 03/13/26 | ||||
| Low | 3.51 on 03/27/26 | ||||
| High | 4.67 on 04/07/26 | ||||
| 3-Month | |||||
| %Chg | -22.49% since 01/15/26 | ||||
| Low | 3.51 on 03/27/26 | ||||
| High | 5.70 on 01/16/26 | ||||
| 6-Month | |||||
| %Chg | +32.52% since 10/15/25 | ||||
| Low | 2.28 on 11/06/25 | ||||
| High | 6.30 on 01/08/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 46,920,000 | ||||
| Annual Net Income | -38,100,000 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -26,908,856 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | 12/31/69 | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||